Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2021 Mar 24;11:6768. doi: 10.1038/s41598-021-86189-z

Alcohol consumption, depression, overweight and cortisol levels as determining factors for NR3C1 gene methylation

Júlia de Assis Pinheiro 1, Flávia Vitorino Freitas 1,2, Aline Ribeiro Borçoi 1, Suzanny Oliveira Mendes 1, Catarine Lima Conti 1, Juliana Krüger Arpini 3, Tamires dos Santos Vieira 1, Rafael Assis de Souza 4, Dirceu Pereira dos Santos 5, Wagner Miranda Barbosa 2, Anderson Barros Archanjo 1, Mayara Mota de Oliveira 1, Joaquim Gasparini dos Santos 1, Bruna Pereira Sorroche 6, José Claudio Casali-da-Rocha 7, Leonardo Oliveira Trivilin 8, Elizeu Batista Borloti 9, Iuri Drumond Louro 1, Lidia Maria Rebolho Batista Arantes 6, Adriana Madeira Alvares-da-Silva 1,10,11,
PMCID: PMC7990967  PMID: 33762648

Abstract

The NR3C1 glucocorticoid receptor (GR) gene is a component of the stress response system, which can be regulated by epigenetic mechanisms. NR3C1 methylation has been associated with trauma and mental issues, including depression, post-traumatic stress, anxiety, and personality disorders. Previous studies have reported that stressful events are involved in NR3C1 gene methylation, suggesting that its regulation under environmental effects is complex. The present study aimed to analyze associations involving stressors such as socioeconomic status, health conditions, and lifestyle in relation to NR3C1 methylation in adults. This study included 386 individual users of the Brazilian Public Unified Health System (SUS), and evaluated socioeconomic and health conditions, body mass index, cortisol levels, and lifestyle. Data were correlated with NR3C1 methylation, determined using DNA pyrosequencing. The results showed that alcohol consumption, overweight, and high cortisol levels were related to NR3C1 demethylation, while depression was related to its methylation. Habits, lifestyle, and health status may influence NR3C1 gene regulation via methylation, revealing the complexity of environmental impacts on NR3C1 methylation.

Subject terms: Epigenetics and behaviour, DNA methylation

Introduction

DNA methylation is a widely known mechanism involved in regulating gene expression1. It has been recently described as the "modus operandi" of environmental adaptation, and in rapid responses to exposure events, which can be passed on to future generations2. Imprinting patterns are inherited and preserved during cell division; however, extrinsic or environmental factors contribute to epigenetic changes during an individual's life35. Therefore, stressful events can result in the addition or withdrawal of epigenetic marks at specific DNA locations, resulting in altered gene expression68.

Stress events in humans or animal models have been related to epigenetic changes in specific regulatory regions of the glucocorticoid receptor (GR) gene encoding, which has the function of regulating hypothalamic stress on the neuroendocrine hypothalamic–pituitary–adrenal (HPA) axis, via cortisol production9,10. Increased cortisol levels have been previously related to stress and methylation1113. Furthermore, other stressful events or conditions, including trauma14, early life stress13,1517, depression10,18,19, nutritional alterations2022, psychosocial stress23, and consumption of substances such as alcohol and tobacco24,25, can alter GR gene encoding methylation levels.

Animal studies have evaluated methylation events directly in the hypothalamus15,26, while human studies have evaluated blood methylation events by their homology observed in different tissues with equivalent expression16.

The GR belongs to the ligand-dependent nuclear receptor transcription factor superfamily and, in humans, it is encoded by the NR3C1 gene, located on chromosome 5q31–q32, with approximately 140,000 base pairs2729. This gene is composed of 17 exons, eight coding exons (numbered 2–9), and nine non-coding exons, which are located in the gene promoter11,30. The NR3C1 promoter region contains multiple methylation-sensitive cytosine-phosphate-guanine (CpG) dinucleotide repeats11,31,32, among these, the 1F region containing 47 CpG sites12,33,34.

NR3C1 promoter methylation is responsible for different GR protein levels in various tissues35,36, such as the heart, kidney, lung, liver, skin, and especially the hippocampus13,3642. Although it is not expressed in T-cells, it is expressed in B-cells and dendritic cells, homologous to the hippocampus; therefore, it can be evaluated in blood under conditions involving HPA axis changes16,43.

NR3C1 promoter methylation may indicate lower mRNA levels and GR expression13,44. Thus, even high levels of peripheral cortisol are unable to bind to the cognate receptor to act as an HPA axis negative feedback mechanism, which could result in abnormal responses to stress33,44. On the contrary, since stress factors are associated with epigenetic changes, we hypothesized that social and behavioral factors may be associated with NR3C1 gene methylation.

It is still unclear what different conditions might alter NR3C1 promoter methylation, especially in broader and multifactorial systems. Thus, the present study aimed to analyze associations involving stressor factors such as socioeconomic status, health conditions, and lifestyle in relation to NR3C1 gene methylation in adult individuals.

Materials and methods

Patient samples

This was a cross-sectional study carried out with users of the Brazilian Public Unified Health System (SUS) in a southeastern municipality (Alegre-ES), and was conducted between March 2017 and November 2018. The study population was composed of individuals living in urban and rural areas, and was approved by The Ethics Committee in Research with Humans of the Universidade Federal do Espírito Santo Health Sciences Center (CEP/CCS/UFES), under number 1,574,160, dated 6/6/2016. Individuals participating in the study signed written informed consent forms (ICFs). All methods were carried out in accordance with the Ethics Committee of Research with Humans.

Population characteristics

This study was made up of a convenient sample of 386 individuals aged between 20 and 59 years who were users of the Brazilian Primary Health Care Units. Based on individual SUS registration forms, data were collected through individual interviews that evaluated socioeconomic, health, and lifestyle conditions. Low-income was defined as a per capita income/day less than US$5 (5 American dollars)45. Marital status, age, working conditions, and education (< 8 years, 8–11 years, and higher education) were also analyzed.

To assess habits and lifestyle features such as alcohol and tobacco consumption, in addition to leisure and physical activity, a structural questionnaire was applied based on the Research Directorate Work Coordination and Income Questionnaire for residents of households from the National Health Survey (NHS)46.

In this evaluation, the possible responses to alcohol and tobacco consumption were: (1) currently consuming, (2) used in the past, (3) never used, and for statistical analysis, responses were dichotomized into current consumption: no/yes. In addition, regarding leisure and physical activity, the possible answers for their activity were: (1) weekly, (2) biweekly, (3) monthly, and (4) not performed, dichotomized into yes/no activity.

In the same questionnaire, we addressed self-perceived health status in which the possible answers were: (1) very good, (2) good, (3) regular, (4) bad, (5) very bad, and were dichotomized into: good or very good/regular or poor health for statistical modeling.

Symptoms suggestive of depression were assessed using the Beck Depression Inventory-II (BDI-II)47. Values were categorized according to Gomes-Oliveira et al.48 considering normal or mild mood disorders (BDI-II < 17), and symptoms suggestive of depression (BDI-II ≥ 17).

Anthropometric assessment was carried out by qualified professionals using the Food and Nutrition Surveillance System (SISVAN)49, which collects information for directing public policies of the Brazilian Unified Health System (SUS). Information such as weight and height were collected, and from the obtained data, body mass index (BMI) was calculated and classified according to the World Health Organization50.

Blood analysis

For analysis of cortisol and vitamin D levels and DNA methylation, 10 mL of peripheral blood was collected from patients by venipuncture after fasting for at least 8 h as instructed by community health agents (CHA). In a tube containing ethylenediaminetetraacetic acid (EDTA) anticoagulant, 3 mL of the sample was transferred for molecular analysis, and 2 mL into a tube containing NaF (sodium fluoride) anticoagulant for vitamin D analysis. The remaining blood was transferred to a tube without anticoagulant but containing a separating gel to obtain serum to determine cortisol levels. The tube contents were homogenized by inversion 5–8 times, and stored in refrigerated coolers over the range of − 2 to 8 °C. Blood samples for biochemical evaluation of cortisol and vitamin D levels were transported to Hermes Pardini Laboratory, Belo Horizonte, MG, while samples for DNA extraction were transported to the Biotechnology Laboratory, at the Center for Exact, Natural and Health Sciences, at the Federal University of Espírito Santo (CCENS/UFES).

Cortisol levels and vitamin D abundance were quantified by chemiluminescence, with reference values for morning cortisol levels of 6.7–22.6 μg/dL17. Results were classified as follows: low cortisol: < 6.7 μg/dL; Normal CORTISOL: 6.7–22.6 μg/dL; high cortisol: serum levels > 22.6 μg/dL. At the data analysis stage, the variable was dichotomized into high cortisol (≥ 6.7 μg/dL) and not high cortisol (< 6.7 μg/dL). Vitamin D levels were classified as deficiency: < 20 ng/mL, insufficiency: 20–29 ng/mL, and sufficiency: ≥ 30 ng/mL, and for statistical evaluation, these scores were dichotomized into insufficiency: < 30 ng/mL, and sufficiency: ≥ 30 ng/mL20,51.

DNA extraction was performed as described by Salazar et al.52. A NanoDrop 2000/2000c Spectrophotometer was used to verify DNA quality and concentration for further NR3C1 methylation analysis.

Quantitative pyrosequencing methylation assay

Of all samples with good DNA quality and concentration, a subsample of 285 patients was randomly assigned to undergo pyrosequencing methylation assays.

Sodium-bisulfite conversion of 1 μg of DNA was performed using the EpiTect Bisulfite Kit (Qiagen, Valencia, CA, USA), following the manufacturer’s recommendations. Pyrosequencing methylation assays were performed as previously described53,54.

PCR product quality was checked on 2% agarose gels using GelRed (Uniscience). Pyrosequencing was performed using a PSQ 96 ID Pyrosequencer (Qiagen, Valencia, CA, USA) with PyroMark Gold Q96 Reagent Kit (Qiagen), according to the manufacturer's protocol. All pyrosequencing conditions are listed in Table 1.

Table 1.

PCR and Pyrosequencing primers and conditions.

PCR primer Conditions
Forward 5′-TTTTTTTTTTGAAGTTTTTTTA-3’ 95 °C (14′30″)
Reverse 5′-BIOTIN-CCCCCAACTCCCCAAAAA-3’ 94 °C (30″)
50 °C (30″) 45 cycles
72 °C (30″) (410 bp)
72 °C (10′)
4 °C Indefinitely
Sequencing primers
40 to 42 CpG 5′-AGAAAAGAAATTGGAGAAATT-3′
43 to 47 CpG 5′-GTTTTAGAGAGATTAGGT-3′
Analyzed sequences
Seq 1 YGGTGGTTTTTTTAAYGTYGTTTTAATCGTGTTGATCAGTCGCTTA
Seq 2 YGGTTTTYGTYGTTGTYGTYGTTAGTCAGTTCAGTCGTAGTCAGTCGTA

A single pyrosequencing reaction was performed for each individual, and the reaction was evaluated for quality. The percentage of methylation was recorded for each CpG from 40 to 47, individually and on average, evaluated in PyroMark Q96 ID Software 2.5 version 2.5.10.7, using default software settings. In this study, we considered all methylation levels detected in pyrosequencing to classify individuals as methylated or unmethylated, when they presented methylation at any percentage above zero.

A representative scheme of the amplified 1F region of NR3C1 and the eight CpGs site-specific analyzed using bisulfite-pyrosequencing assays are shown in Fig. 1.

Figure 1.

Figure 1

Promoter region of NR3C1 examined within this study. The CpGs studied (40-47) are represented in red and are also numbered. Lowercase nucleotides represent intronic regions, while uppercase nucleotides represent exon 1F. GenBank (NCBI—Access number: AY436590.1).

Statistical analysis

Data were analyzed using Chi-squared tests in a 2 × 2 contingency table and a statistical significance level of 5%. Quantitative data are expressed as median and interquartile ranges.

Results of quantitative analysis of NR3C1 gene methylation did not follow a normal distribution, even after exponential conversion. In this manner, the methylation data were dichotomized. The mean methylation values of CGs segment from 40 to 47 were calculated for qualitative analysis such that values > 0 were categorized as methylated, and values equal to 0 were categorized as unmethylated. Then, applied bivariate analyses were performed using Poisson regression models with robust variance, with the dependent variable being methylation of the segment, and as explanatory variables socioeconomic aspects, health, and lifestyle, as well as suggestive symptoms of depression. After data characterization, independent variables were recategorized dichotomously according to the classifications in normal state/altered states before being included in the multivariate study model.

Predictive variables that achieved p values lower than 0.20 (p < 0.20) were inserted into the multivariate Poisson regression model with robust variance. The backward method was used, and those variables with less significance (greater p value) were removed one by one from the model. The procedure was repeated until all variables present in the model were statistically significant (p < 0.05). The Hosmer–Lemeshow test was used to verify the fit of the final model. The prevalence ratio (PR) with 95% confidence interval (95% CI) was used as an effect measure. For all analyses, a significance level of 5% was adopted. Statistical analyses were performed using SPSS software (v.13.0 for Windows) and Stata v.11.0.

Results

Socioeconomic profile

Our results were obtained from a total of 285 individuals evaluated by pyrosequencing of the NR3C1 1F region; 198 individuals did not show any percentage of methylation detected, whereas 87 exhibited measurable percentages of methylation. The median methylation level was 0.0 (0.0–12.9%). Table 2 presents a population description, which was divided into unmethylated and methylated. Individuals were predominantly female (80.6%), 75% lived with a partner, and the median age was 42.5 (33.7–52.0) years. Most of them had < 8 years of formal education (46.4%), low income (70.2%), did not drink, smoke, or perform physical or leisure activities.

Table 2.

Sample characteristics according to methylation of 1F region NR3C1 gene.

Characteristic Total Methylation p
No Yes
N (%) N (%) N (%)
Gender
Male 60 21.0 50 17.5 10 3.5 0.009*
Female 225 79.0 148 52.0 77 27.0
Age (years)
20–40  125 43.8 87 30.5 38 13.3 0.967
41–60  160 56.2 111 39.0 49 17.2
Marital status
Single 70 24.6 55 19.3 15 5.3 0.057
No single 215 75.4 143 50.2 72 25.2
Education
Basic education 240 84.2 167 58.6 73 25.6 0.926
Higher education 45 15.8 31 10.9 14 4.9
Working
Yes 151 53.0 103 36.2 48 16.8 0.623
No 134 47.0 95 33.3 39 13.7
Income
Non-low income (≥ $5.00/day) 81 28.4 58 20.4 23 8.0 0.623
Low income (< $5.00/day) 204 71.6 140 49.1 64 22.5
Tobacco consumption
No 261 91.6 176 61.8 85 29.8 0.014*
Yes 24 8.4 22 7.7 2 0.7
Alcohol consumption
No 201 70.2 125 43.9 75 26.3 0.000*
Yes 84 29.8 73 25.6 12 4.2
Weekly drinking
 < 7 drinks 64 76.2 53 63.1 11 13.1 0.438
 > 7 drinks 20 23.8 18 21.4 2 2.4
Physical activity
Yes 95 33.3 69 24.2 26 9.1 0.413
No 190 66.7 129 45.3 61 21.4
Leisure activity
Yes 132 46.3 97 34.1 35 12.3 0.172
No 253 53.7 101 35.4 52 18.2
Self-rated health
Good or very good 145 50.9 105 36.8 40 14.0 0.273
Regular or poor 140 49.1 93 32.6 47 16.5
Depression
BDI-II < 17 194 68.1 136 51.3 58 21.9 0.142
BDI-II ≥ 17 71 24.9 43 16.2 28 10.6
Not available# 20 7.0
Body mass index—BMI
No overweight 96 33.7 59 20.7 37 13.0 0.036*
Overweight 189 66.3 139 48.8 50 17.5
Vitamin D
Sufficiency 264 92.6 185 64.9 79 27.7 0.434
Deficiency 21 7.4 13 4.6 8 2.8
High cortisol levels
No 270 94.7 185 67.0 85 30.8 0.107
Yes 6 2.1 6 2.2 0 0.0
Not available# 9 3.2
Total 285 100.00 198 69.50 87 30.50

BDI-II Beck Depression Inventory-II, BFIS Brazilian Food Insecurity Scale, FNS Food and Nutrition Security, FNiS Food and Nutrition Insecurity, BMI Body Mass Index. #Not available (not considered in the statistical calculations). Categorical variables presented in relative (%) and absolute (n) frequencies. Quantitative variables presented in medians and interquartile ranges (IR), according to normality (Kolmogorov–Smirnov test); * p value: Mann–Whitney U or chi-square, at 5% significance (p < 0.05).

Methylation analysis of NR3C1

The average methylation index was calculated from CpG sites methylation percentages. These percentages were dichotomized into unmethylated (0% methylation) and methylated (values > 0% methylated).

Bivariate Poisson regression showed associations between methylation profiles and gender (p = 0.047), alcohol consumption (p < 0.001), depression (p = 0.022), body index (p = 0.017), and cortisol levels (p < 0.001) (Table 3).

Table 3.

Bivariate Poisson regression analysis with robust variance for NR3C1 1F region methylation.

Characteristics Methylation
(CpG 40–47)
PR 95% CI p
Gender
Male 1.8 1.00–3.41 0.047
Female
Age (years)
20–40  1.0 0.70–1.47 0.938
41–60 
Marital status
Single 1.6 0.95–2.63 0.073
Not single
Education
Basic education 0.9 0.55–1.54 0.779
Higher education
Working
Yes 0.9 0.67–1.43 0.785
No
Income
Non-low income (≥ $5.00/day) 1.2 0.77–1.80 0.443
Low income (< $5.00/day)
Tobacco consumption
No 0.2 0.69–1.04 0.058
Yes
Alcohol consumption
No 0.3 0.16–0.53  < 0.001
Yes
Physical activity
Yes 1.1 0.76–1.72 0.500
No
Leisure activity
Yes 1.2 0.87–1.87 0.196
No
Self-rated health
Good or very good 1.3 0.90–1.91 0.147
Regular or poor
Depression
BDI-II < 17 1.5 1.06–2.27 0.022
BDI-II ≥ 17
Body mass index—BMI
Not overweight 0.6 0.44–0.92 0.017
Overweight
Vitamin D
Sufficiency 1.2 0.69–2.40 0.413
Deficiency
High cortisol levels
No 2.2–9 1.11–9–4.65–9  < 0.001
Yes

Bold values indicate significance result.

PR prevalence ratio, 95% CI confidence interval, p p value.

From variables in the Bivariate Poisson regression with values p < 0.20, the multivariate model was designed. The results showed that methylation is associated with alcohol consumption, depression, BMI, and high cortisol levels (Table 4).

Table 4.

Multivariate Poisson regression analysis with robust variance for methylation of NR3C1 1F region.

Characteristic Methylation
(CpG 40–47)
PR 95% CI p
Alcohol consumption
No
Yes 0.30 0.16–053  < 0.001
Depression
BDI-II < 17
BDI-II ≥ 17 1.55 1.07–2.24 0.018
Body mass index—BMI
Not overweight
Overweight 0.66 0.46–0.95 0.017
High cortisol levels
No
Yes 0.09–5 3.8–7–1.9–6  < 0.001

Bold values indicate significance result.

PR prevalence ratio, 95% CI confidence interval, p p value.

As observed in Table 4, alcohol consumption was associated to 70% decrease in the prevalence of methylation (1–0.30 × 100); being overweight showed a 34% lower prevalence of methylation than not being overweight (1–0.66 × 100), and high cortisol was associated with a lower prevalence of methylation, however with a measure of low effect PR = 0.09–5. In contrast, depression exhibited the opposite effect, being directly related to methylation with prevalence of 55% higher than non-depressed individuals (1.55 times more prevalent).

The final model was statistically significant (p < 0.001), presenting a pseudo r2 = 0.0759 and, after adjustment by Hosmer and Lemeshow, showed good adherence (p = 0.99).

Discussion

This study presents individuals with low income, low education, and predominantly of female gender. Our goal was to establish a broader assessment of factors related to NR3C1 gene methylation, such as socioeconomic aspects, health, and lifestyle.

We have shown that alcohol consumption, overweight, and high cortisol levels are related to NR3C1 non-methylation, while depression is related to its methylation. Argentieri et al.16 presented a series of studies that related hyper- or hypomethylation with specific CpG methylation of this gene.

Few studies have evaluated the relationship between methylation patterns and alcohol consumption. It was expected that alcohol as a stressor factor could stimulate the HPA axis by increasing cortisol levels and NR3C1 methylation. Gatta et al.24 reported hypermethylation of NR3C1 exon 1H in the prefrontal cortex of individuals with alcohol abuse disorders compared with that in a control group. However, our data showed low levels of NR3C1 1F region methylation. Corroborating our findings, Dogan et al.25 showed a relationship between alcohol consumption and decreased levels of NR3C1 methylation in a 64-patient cohort.

Studies have demonstrated that alcohol consumption may lead to HPA axis alterations, with glucocorticoid release modifications55,56. Here, we showed association between alcohol consumption and NR3C1 methylation, which indicated that alcohol-mediated modulation of the HPA axis may occur through epigenetic changes.

Although self-reporting of alcohol consumption was insufficient to control its effects on NR3C1 methylation, our finding is relevant because alcohol represents a large fraction of the drugs consumed by the world population, and the epigenetic effects induced by its consumption are still little known.

Our analysis showed an association between suggestive symptoms of depression, as evaluated by Beck scores ≥ 17, with increased methylation at NR3C1 40–47 1F CpGs sites. Other authors have associated methylation alterations in the 1F region CpG 36–39 sites with depressive status in adolescents57 and in CpGs 36–44 on maternal exposure to gestational stress and depression in children58.

In addition, other authors have studied the 1F region, showing hypomethylation involving CpGs 35–47, with hypomethylation specifically of CpG 43 associated with depression59. There are also studies addressing the 1F region showing hypomethylation of CpGs 35–39 in individuals with depression19. However, the present study provides new information that individuals with depressive symptoms, and frequent use of the public health system, exhibit methylation of the NR3C1 1F region.

In this manner, it is possible that NR3C1 methylation is associated with depression, in that NR3C1 gene methylation may indicate lower mRNA levels and GR expression, leading to imbalanced HPA axis modulation, which could result in abnormal responses to stress, and increase susceptibility to depression33,44.

Furthermore, high cortisol levels were associated with non-methylation, but with a very low prevalence ratio (Table 4). High levels of cortisol have already been related to NR3C1 gene methylation in maternal and postnatal gestational exposure to childhood stress14,33,60.In our study, only 8 individuals presented high cortisol levels, while the others had normal or low levels, but which may not be representative.

On the contrary, multivariate analysis of risk factors showed that being overweight is associated with non-methylation, with a prevalence ratio of 0.67, indicating that being overweight reduces the prevalence of methylation by 33%. Chronic stress has previously been related to increased cortisol levels, leading to weight gain61. Excess weight is also related to chronic inflammation through NFκB pathways; however, no association between overweight and methylation status has been previously reported for the NR3C1 gene62. It is possible that hypomethylation of this region may be related to low-grade inflammation, a feature of the overweight state63.

Although it was a cross-sectional study, and it is not possible to establish any causal relationships, this study is relevant as it revealed a direct or inverse association between methylation, alcohol consumption, overweight, and high cortisol levels related to NR3C1 non-methylation, whereas depression was related to methylation.

Thus, we suggest that habits, lifestyle, and health status may influence NR3C1 gene regulation via methylation. Relationships involving genotype, environment, and phenotypic outcomes may be more refined than previously thought, depending on specific stressful events that can result in unique clinical consequences.

Acknowledgements

We thank the volunteers who participated in this study, Community Health Agents, and the entire team of the Public Unified Health System of the Municipality of Alegre, ES, Brazil, Fundação de Apoio à Pesquisa do Espírito Santo (FAPES, SUS Research Project PPSUS) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq grant number 424130/2018-1) for funding. We also would like to thank Editage (www.editage.com) for English language editing.

Author contributions

J.A.P. and A.M.A.S. conceived and designed of the study. F.V.F., A.R.B., C.L.C., J.K.A., T.S.V., R.A.S., D.P.S., W.M.B., A.B.A., E.B.B. collected sample and all data. J.K.A., M.M.O, J.G.S., B.P.S., L.M.R.B.A. performed molecular analysis. F.V.F., A.R.B., S.O.M., C.L.C., L.O.T., L.M.R.B.A. assisted with data analysis and interpretation of findings. S.O.M., J.C.C.R., L.O.T, I.D.L. performed a critical review of the manuscript. And J.A.P, L.M.R.B.A., A.M.A.S. drafted the manuscript. All authors critically reviewed content and approved final version for publication.

Funding

This work was carried out with the support of the Higher Education Personnel Improvement Coordination-Brazil (CAPES)-Financing Code 001.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Chen D, Meng L, Pei F, Zheng Y, Leng J. A review of DNA methylation in depression. J. Clin. Neurosci. 2017;43:39–46. doi: 10.1016/j.jocn.2017.05.022. [DOI] [PubMed] [Google Scholar]
  • 2.Vidaki A, Daniel B, Court DS. Forensic DNA methylation profiling–potential opportunities and challenges. Forensic Sci. Int. Genet. 2013;7:499–507. doi: 10.1016/j.fsigen.2013.05.004. [DOI] [PubMed] [Google Scholar]
  • 3.Kader F, Ghai M. DNA methylation-based variation between human populations. Mol. Genet. Genom. 2017;292:5–35. doi: 10.1007/s00438-016-1264-2. [DOI] [PubMed] [Google Scholar]
  • 4.Kader F, Ghai M, Maharaj L. The effects of DNA methylation on human psychology. Behav. Brain Res. 2018;346:47–65. doi: 10.1016/j.bbr.2017.12.004. [DOI] [PubMed] [Google Scholar]
  • 5.Lacal I, Ventura R. Epigenetic inheritance: Concepts, mechanisms and perspectives. Front. Mol. Neurosci. 2018;11:292. doi: 10.3389/fnmol.2018.00292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23–38. doi: 10.1038/npp.2012.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yang X, et al. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 2014;26:577–590. doi: 10.1016/j.ccr.2014.07.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Keller TE, Han P, Yi SV. Evolutionary transition of promoter and gene body DNA methylation across invertebrate–vertebrate boundary. Mol. Biol. Evol. 2016;33:1019–1028. doi: 10.1093/molbev/msv345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Weaver IC, et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004;7:847–854. doi: 10.1038/nn1276. [DOI] [PubMed] [Google Scholar]
  • 10.Nantharat M, Wanitchanon T, Amesbutr M, Tammachote R, Praphanphoj V. Glucocorticoid receptor gene (NR3C1) promoter is hypermethylated in Thai females with major depressive disorder. Genet. Mol. Res. 2015;14:19071–19079. doi: 10.4238/2015.December.29.15. [DOI] [PubMed] [Google Scholar]
  • 11.Palma-Gudiel H, Cordova-Palomera A, Leza JC, Fananas L. Glucocorticoid receptor gene (NR3C1) methylation processes as mediators of early adversity in stress-related disorders causality: A critical review. Neurosci. Biobehav. Rev. 2015;55:520–535. doi: 10.1016/j.neubiorev.2015.05.016. [DOI] [PubMed] [Google Scholar]
  • 12.Radtke KM, et al. Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor. Transl. Psychiatry. 2011;1:e21. doi: 10.1038/tp.2011.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.McGowan PO, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009;12:342–348. doi: 10.1038/nn.2270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yehuda R, et al. Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol. Psychiatr. 2015;77:356–364. doi: 10.1016/j.biopsych.2014.02.006. [DOI] [PubMed] [Google Scholar]
  • 15.McGowan PO, et al. Broad epigenetic signature of maternal care in the brain of adult rats. PLoS One. 2011;6:e14739. doi: 10.1371/journal.pone.0014739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Argentieri MA, Nagarajan S, Seddighzadeh B, Baccarelli AA, Shields AE. Epigenetic pathways in human disease: The impact of DNA methylation on stress-related pathogenesis and current challenges in biomarker development. EBioMedicine. 2017;18:327–350. doi: 10.1016/j.ebiom.2017.03.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Silva BC, et al. Subclinical Cushing's disease: Presentation of three cases and critical review. Arq. Bras. Endocrinol. Metabol. 2007;51:625–630. doi: 10.1590/s0004-27302007000400018. [DOI] [PubMed] [Google Scholar]
  • 18.Borçoi AR, Oliveira SM, dos Santos JG, et al. Risk factors for depression in adults: NR3C1 DNA methylation and lifestyle association. J. Psychiatr. Res. 2020;16(121):24–30. doi: 10.1016/j.jpsychires.2019.10.011. [DOI] [PubMed] [Google Scholar]
  • 19.Na KS, et al. Association between glucocorticoid receptor methylation and hippocampal subfields in major depressive disorder. PLoS One. 2014;9:e85425. doi: 10.1371/journal.pone.0085425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Holick MF, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011;96:1911–1930. doi: 10.1210/jc.2011-0385. [DOI] [PubMed] [Google Scholar]
  • 21.Amenyah SD, Hughes CF, Ward M, Rosborough S, Deane J, Thursby S-J, et al. Influence of nutrients involved in one-carbon metabolism on DNA methylation in adults—a systematic review and meta-analysis. Nutr. Rev. 2020 doi: 10.1093/nutrit/nuz094. [DOI] [PubMed] [Google Scholar]
  • 22.Zhang N. Epigenetic modulation of DNA methylation by nutrition and its mechanisms in animals. Anim. Nutr. 2015;1:144–151. doi: 10.1016/j.aninu.2015.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Uddin M, Jansen S, Telzer EH. Adolescent depression linked to socioeconomic status? Molecular approaches for revealing premorbid risk factors. BioEssays. 2017;39(3):1600194. doi: 10.1002/bies.201600194. [DOI] [PubMed] [Google Scholar]
  • 24.Gatta E, Grayson DR, Auta J, et al. Genome-wide methylation in alcohol use disorder subjects: Implications for an epigenetic regulation of the cortico-limbic glucocorticoid receptors (NR3C1) [published online ahead of print, 2019 Jun 25] Mol. Psychiatry. 2019 doi: 10.1038/s41380-019-0449-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Dogan MV, Lei MK, Beach SR, Brody GH, Philibert RA. Alcohol and tobacco consumption alter hypothalamic pituitary adrenal axis DNA methylation. Psychoneuroendocrinology. 2016;66:176–184. doi: 10.1016/j.psyneuen.2016.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Alt SR, et al. Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology. 2010;35:544–556. doi: 10.1016/j.psyneuen.2009.09.001. [DOI] [PubMed] [Google Scholar]
  • 27.Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease. J. Allergy Clin. Immunol. 2013;132:1033–1044. doi: 10.1016/j.jaci.2013.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Steiger H, Labonte B, Groleau P, Turecki G, Israel M. Methylation of the glucocorticoid receptor gene promoter in bulimic women: Associations with borderline personality disorder, suicidality, and exposure to childhood abuse. Int. J. Eat. Disord. 2013;46:246–255. doi: 10.1002/eat.22113. [DOI] [PubMed] [Google Scholar]
  • 29.Turner JD, Vernocchi S, Schmitz S, Muller CP. Role of the 5'-untranslated regions in post-transcriptional regulation of the human glucocorticoid receptor. Biochem. Biophys. Acta. 1839;1051–1061:2014. doi: 10.1016/j.bbagrm.2014.08.010. [DOI] [PubMed] [Google Scholar]
  • 30.Daskalakis NP, Yehuda R. Site-specific methylation changes in the glucocorticoid receptor exon 1F promoter in relation to life adversity: Systematic review of contributing factors. Front. Neurosci. 2014;8:369. doi: 10.3389/fnins.2014.00369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Brenet F, et al. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One. 2011;6:e14524. doi: 10.1371/journal.pone.0014524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Provencal N, Binder EB. The effects of early life stress on the epigenome: From the womb to adulthood and even before. Exp. Neurol. 2015;268:10–20. doi: 10.1016/j.expneurol.2014.09.001. [DOI] [PubMed] [Google Scholar]
  • 33.Oberlander TF, et al. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics. 2008;3:97–106. doi: 10.4161/epi.3.2.6034. [DOI] [PubMed] [Google Scholar]
  • 34.Murgatroyd C, Quinn JP, Sharp HM, Pickles A, Hill J. Effects of prenatal and postnatal depression, and maternal stroking, at the glucocorticoid receptor gene. Transl. Psychiatry. 2015;5:e560. doi: 10.1038/tp.2014.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Presul E, Schmidt S, Kofler R, Helmberg A. Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. J. Mol. Endocrinol. 2007;38:79–90. doi: 10.1677/jme.1.02183. [DOI] [PubMed] [Google Scholar]
  • 36.Yan K, et al. Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int. 1999;56:65–73. doi: 10.1046/j.1523-1755.1999.00503.x. [DOI] [PubMed] [Google Scholar]
  • 37.Ito K, Getting SJ, Charron CE. Mode of glucocorticoid actions in airway disease. Sci. World J. 2006;6:1750–1769. doi: 10.1100/tsw.2006.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Chebotaev D, Yemelyanov A, Budunova I. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin. Mol. Carcinog. 2007;46:732–740. doi: 10.1002/mc.20349. [DOI] [PubMed] [Google Scholar]
  • 39.Mueller KM, et al. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Mol. Cell. Endocrinol. 2012;361:1–11. doi: 10.1016/j.mce.2012.03.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Panagiotou C, Mihailidou C, Brauhli G, Katsarou O, Moutsatsou P. Effect of steviol, steviol glycosides and stevia extract on glucocorticoid receptor signaling in normal and cancer blood cells. Mol. Cell. Endocrinol. 2018;460:189–199. doi: 10.1016/j.mce.2017.07.023. [DOI] [PubMed] [Google Scholar]
  • 41.Richardson RV, et al. Glucocorticoid receptor alters isovolumetric contraction and restrains cardiac fibrosis. J. Endocrinol. 2017;232:437–450. doi: 10.1530/JOE-16-0458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wang W, et al. Increased methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of patients with generalized anxiety disorder. J. Psychiatr. Res. 2017;91:18–25. doi: 10.1016/j.jpsychires.2017.01.019. [DOI] [PubMed] [Google Scholar]
  • 43.Turner JD, Muller CP. Structure of the glucocorticoid receptor (NR3C1) gene 5' untranslated region: Identification, and tissue distribution of multiple new human exon 1. J. Mol. Endocrinol. 2005;35:283–292. doi: 10.1677/jme.1.01822. [DOI] [PubMed] [Google Scholar]
  • 44.Perroud N, Dayer A, Piguet C, Nallet A, Favre S, Malafosse A, Aubry JM. Childhood maltreatment and methylation of the glucocorticoid receptor gene NR3C1 in bipolar disorder. Br. J. Psychiatry. 2014;204:30–35. doi: 10.1192/bjp.bp.112.120055. [DOI] [PubMed] [Google Scholar]
  • 45.Neri M. C. FGV/IBRE, CPS A Nova Classe Média. ed. CPS FGV/IBRE. Editora Fundação Getúlio Vargas, Rio de Janeiro. 70 (2008).
  • 46.Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde 2013: Percepção do estado de saúde, estilos de vida e doenças crônicas. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2014. https://www.pns.icict.fiocruz.br/index.php?pag=proposicao.
  • 47.Jackson-Koku G. Beck Depression Inventory. Occup. Med. 2016;66:174–175. doi: 10.1093/occmed/kqv087. [DOI] [PubMed] [Google Scholar]
  • 48.Gomes-Oliveira MH, Gorenstein C, Lotufo Neto F, Andrade LH, Wang YP. Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample. Rev. Bras. Psiquiatr. 2012;34:389–394. doi: 10.1016/j.rbp.2012.03.005. [DOI] [PubMed] [Google Scholar]
  • 49.Ministério da Saude, S. Orientações para a coleta e análise de dados antropométricos em serviços de saúde : Norma Técnica do Sistema de Vigilância Alimentar e Nutricional. Secretaria de Atenção à Saúde Departamento de atenção Básica de 2011 (2011).
  • 50.WHO, W. H. O. Institutes Health of National 1, 1–22 (2017).
  • 51.Holick MF. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266–281. doi: 10.1056/NEJMra070553. [DOI] [PubMed] [Google Scholar]
  • 52.Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RD. Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin. Chem. 1998;44:1748–1750. doi: 10.1093/clinchem/44.8.1748. [DOI] [PubMed] [Google Scholar]
  • 53.Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques. 2003;35:146–150. doi: 10.2144/03351md01. [DOI] [PubMed] [Google Scholar]
  • 54.Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by pyrosequencing. Biotechniques. 2003;35:152–156. doi: 10.2144/03351md02. [DOI] [PubMed] [Google Scholar]
  • 55.Blaine SK, Sinha R. Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders. Neuropharmacology. 2017;122:136–147. doi: 10.1016/j.neuropharm.2017.01.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Richardson HN, Lee SY, O'Dell LE, Koob GF, Rivier CL. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur. J. Neurosci. 2008;28(8):1641–1653. doi: 10.1111/j.1460-9568.2008.06455.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Efstathopoulos P, et al. NR3C1 hypermethylation in depressed and bullied adolescents. Transl. Psychiatry. 2018;8:121. doi: 10.1038/s41398-018-0169-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Braithwaite EC, Kundakovic M, Ramchandani PG, Murphy SE, Champagne FA. Maternal prenatal depressive symptoms predict infant NR3C1 1F and BDNF IV DNA methylation. Epigenetics. 2015;10:408–417. doi: 10.1080/15592294.2015.1039221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Song Y, et al. Altered DNA methylation status of human brain derived neurotrophis factor gene could be useful as biomarker of depression. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2014;165B:357–364. doi: 10.1002/ajmg.b.32238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Hompes T, et al. Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood. J. Psychiatr. Res. 2013;47:880–891. doi: 10.1016/j.jpsychires.2013.03.009. [DOI] [PubMed] [Google Scholar]
  • 61.Jackson SE, Steptoe A. Obesity, perceived weight discrimination, and hair cortisol: A population-based study. Psychoneuroendocrinology. 2018;98:67–73. doi: 10.1016/j.psyneuen.2018.08.018. [DOI] [PubMed] [Google Scholar]
  • 62.Milagro FI, Mansego ML, De Miguel C, Martinez JA. Dietary factors, epigenetic modifications and obesity outcomes: Progresses and perspectives. Mol. Aspects Med. 2013;34:782–812. doi: 10.1016/j.mam.2012.06.010. [DOI] [PubMed] [Google Scholar]
  • 63.Freitas FV, et al. Psychosocial stress and central adiposity: A Brazilian study with a representative sample of the public health system users. PLoS One. 2018;13:e0197699. doi: 10.1371/journal.pone.0197699. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES